August 01, 2014 4:42 AM ET

Pharmaceuticals

Company Overview of Elixir Pharmaceuticals, Inc.

Executive Profile

John J. Kopchick Ph.D.

Member of Scientific Advisory Board, Elixir Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

John J. Kopchick, Ph.D. is a Professor of Molecular Biology at the Ohio University College of Osteopathic Medicine and Edison Biotechnology Institute. Dr. Kopchick research focuses on the molecular and cellular events involved in growth, obesity, and diabetes. He serves as Member of Scientific Advisory Board of Elixir Pharmaceuticals, Inc. Dr. Kopchick earned his Ph.D. in Virology-Biomedical Sciences from the Graduate School of Biomedical Sciences at the University of ...

Corporate Headquarters

300 Putnam Avenue
Cambridge, Massachusetts 02139

United States

Phone: 617-995-7000
Fax: 617-995-7050

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
UTHSCSA Graduate School of Biomedical Sciences

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Elixir Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.